Jasper Therapeutics (JSPR) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free JSPR Stock Alerts $22.94 -0.08 (-0.35%) (As of 03:03 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Jasper Therapeutics Short Interest DataCurrent Short Interest614,400 sharesPrevious Short Interest492,400 sharesChange Vs. Previous Month+24.78%Dollar Volume Sold Short$14.67 millionShort Interest Ratio5.4 Days to CoverLast Record DateApril 30, 2024Outstanding Shares15,060,000 sharesFloat Size11,800,000 sharesShort Percent of Float5.21%Today's Trading Volume24,032 sharesAverage Trading Volume108,281 sharesToday's Volume Vs. Average22% Short Selling Jasper Therapeutics ? Sign up to receive the latest short interest report for Jasper Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartJSPR Short Interest Over TimeJSPR Days to Cover Over TimeJSPR Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Jasper Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024614,400 shares $14.67 million +24.8%5.2%5.4 $23.87 4/15/2024492,400 shares $12.95 million +9.0%4.2%4.4 $26.30 3/31/2024451,900 shares $13.27 million +38.1%3.8%3.5 $29.36 3/15/2024327,300 shares $8.21 million +13.3%2.8%2.6 $25.08 2/29/2024288,900 shares $6.14 million +2.5%2.7%2.1 $21.25 2/15/2024282,000 shares $5.06 million +2.1%2.7%2.2 $17.95 Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024276,200 shares $3.25 million +43.5%3.4%2.5 $11.78 1/15/2024192,500 shares $1.62 million +4.5%2.4%2.2 $8.39 12/31/2023184,300 shares $1.45 million -90.4%2.3%3 $7.89 12/15/20231,910,000 shares $924,058.00 +0.5%2.4%3.1 $0.48 11/30/20231,900,000 shares $1.17 million +2.7%2.4%4.8 $0.61 11/15/20231,850,000 shares $1.06 million +1.1%2.3%5.3 $0.57 10/31/20231,830,000 shares $1.21 million -2.7%2.3%5.5 $0.66 10/15/20231,880,000 shares $1.64 million +6.8%2.4%5.7 $0.87 9/30/20231,760,000 shares $1.23 million +45.5%2.2%5.2 $0.70 9/15/20231,210,000 shares $992,200.00 +11.0%1.5%3.7 $0.82 8/31/20231,090,000 shares $1.34 million +9.0%1.4%4.1 $1.23 8/15/2023999,600 shares $1.44 million -1.0%1.3%3.6 $1.44 7/31/20231,010,000 shares $1.53 million +19.5%1.3%3.3 $1.51 7/15/2023845,500 shares $1.19 million +3.3%1.1%2.5 $1.41 6/30/2023818,600 shares $1.12 million +13.2%1.0%1.6 $1.37 6/15/2023723,100 shares $1.06 million -16.1%0.9%1.4 $1.47 5/31/2023861,500 shares $1.34 million -18.0%1.1%1.3 $1.55 5/15/20231,050,000 shares $1.64 million -16.7%1.3%1.2 $1.56 4/30/20231,260,000 shares $1.68 million -67.5%1.7%1.2 $1.33 4/15/20233,880,000 shares $5.63 million +5.7%4.8%2.9 $1.45 3/31/20233,670,000 shares $6.64 million +20.7%4.4%1.4 $1.81 3/15/20233,040,000 shares $5.78 million -12.1%3.6%0.8 $1.90 2/28/20233,460,000 shares $6.68 million +46.0%4.1%1 $1.93 2/15/20232,370,000 shares $4.14 million +76.9%2.8%0.7 $1.75 1/31/20231,340,000 shares $2.28 million +52.0%1.6%0.4 $1.70 1/15/2023881,800 shares $1.57 million +240.7%6.9%0.3 $1.78 12/30/2022258,800 shares $124,974.52 +21.6%2.0%0.1 $0.48 12/15/2022212,900 shares $137,022.44 +48.1%1.7%3.2 $0.64 11/30/2022143,800 shares $90,306.40 +30.6%1.2%2.2 $0.63 11/15/2022110,100 shares $71,565.00 +37.6%0.9%1.6 $0.65 10/31/202280,000 shares $58,400.00 +78.6%0.7%1.1 $0.73 10/15/202244,800 shares $32,475.52 -54.2%0.4%0.6 $0.72 9/30/202297,800 shares $77,173.98 +1,170.1%0.7%1.4 $0.79 9/15/20227,700 shares $10,010.00 -89.9%0.1%0.1 $1.30**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 8/31/202276,400 shares $145,160.00 -25.3%0.6%1.8 $1.90 8/15/2022102,300 shares $214,830.00 -7.3%0.8%2.8 $2.10 7/31/2022110,300 shares $208,467.00 -6.6%0.8%3.2 $1.89 7/15/2022118,100 shares $227,933.00 -9.7%0.9%2.7 $1.93 6/30/2022130,800 shares $252,444.00 +96.4%1.0%3.1 $1.93 6/15/202266,600 shares $133,866.00 -26.6%0.5%1.2 $2.01 5/31/202290,700 shares $287,519.00 -5.6%0.7%1.6 $3.17 5/15/202296,100 shares $287,339.00 -31.8%0.7%1.3 $2.99 4/30/2022140,900 shares $429,745.00 +15.4%1.1%1.7 $3.05 4/15/2022122,100 shares $347,985.00 -6.6%1.0%1.5 $2.85 3/31/2022130,700 shares $463,985.00 -30.6%1.1%1.4 $3.55 3/15/2022188,400 shares $580,272.00 -36.3%1.5%2 $3.08 2/28/2022295,900 shares $1.11 million +3.6%2.4%1.9 $3.75 2/15/2022285,500 shares $1.32 million -36.4%2.3%1.6 $4.63 1/31/2022448,900 shares $2.12 million +2.1%3.6%2.1 $4.73 1/15/2022439,700 shares $2.54 million -10.4%3.5%1.4 $5.77 12/31/2021490,800 shares $3.85 million No Change4.0%0.2 $7.85 JSPR Short Interest - Frequently Asked Questions What is Jasper Therapeutics' current short interest? Short interest is the volume of Jasper Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 614,400 shares of JSPR short. 5.21% of Jasper Therapeutics' shares are currently sold short. Learn More on Jasper Therapeutics' current short interest. What is a good short interest ratio for Jasper Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JSPR shares currently have a short interest ratio of 5.0. Learn More on Jasper Therapeutics's short interest ratio. Which institutional investors are shorting Jasper Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jasper Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Jasper Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.21% of Jasper Therapeutics' floating shares are currently sold short. Is Jasper Therapeutics' short interest increasing or decreasing? Jasper Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 614,400 shares, an increase of 24.8% from the previous total of 492,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Jasper Therapeutics' float size? Jasper Therapeutics currently has issued a total of 15,060,000 shares. Some of Jasper Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Jasper Therapeutics currently has a public float of 11,800,000 shares. How does Jasper Therapeutics' short interest compare to its competitors? 5.21% of Jasper Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Jasper Therapeutics: DocGo Inc. (10.25%), Anavex Life Sciences Corp. (25.15%), Caribou Biosciences, Inc. (13.35%), MeiraGTx Holdings plc (1.76%), SOPHiA GENETICS SA (0.11%), Tenaya Therapeutics, Inc. (5.80%), Candel Therapeutics, Inc. (6.70%), Black Diamond Therapeutics, Inc. (3.56%), Invivyd, Inc. (9.65%), Adaptimmune Therapeutics plc (1.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Jasper Therapeutics stock? Short selling JSPR is an investing strategy that aims to generate trading profit from Jasper Therapeutics as its price is falling. JSPR shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Jasper Therapeutics? A short squeeze for Jasper Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JSPR, which in turn drives the price of the stock up even further. How often is Jasper Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JSPR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DCGO Short Interest Data AVXL Short Interest Data CRBU Short Interest Data MGTX Short Interest Data SOPH Short Interest Data TNYA Short Interest Data CADL Short Interest Data BDTX Short Interest Data IVVD Short Interest Data ADAP Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JSPR) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts